Evidence map›Paper›PMID 29379077›Full record

ArticleScientific reports2018

Immunomodulatory capacity of the serotonin receptor 5-HT2B in a subset of human dendritic cells.

Attila Szabo, Peter Gogolak, Gabor Koncz, Zsofia Foldvari, Kitti Pazmandi, Noemi Miltner, Szilard Poliska, Attila Bacsi, Srdjan Djurovic, Eva Rajnavolgyi

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 81 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Psychedelic therapy and postpartum depression: priorities and prospects.Therapeutic advances in psychopharmacology · 2026
    Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Role of mechanosensitive channel Piezo1 protein in intestinal inflammation regulation: A potential target.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2024
    Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Attila SzaboNORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Norway. attila.szabo@medisin.uio.no.
Peter GogolakDepartment of Immunology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
Gabor KonczDepartment of Immunology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
Zsofia FoldvariDepartment of Immunology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
Kitti PazmandiDepartment of Immunology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
Noemi MiltnerDepartment of Immunology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
Szilard PoliskaDepartment of Biochemistry and Molecular Biology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
Attila BacsiDepartment of Immunology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
Srdjan DjurovicNORMENT, KG Jebsen Centre for Psychosis Research, Department of Clinical Science, University of Bergen, Bergen, Norway.
Eva RajnavolgyiDepartment of Immunology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
University of Debrecen · HUOslo University Hospital · NOUniversity of Oslo · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Serotonin is a monoamine neurotransmitter that signals through a wide array of receptors (5-HT

Indexed as

Antigens, CD1CD4-Positive T-LymphocytesCell DifferentiationCells, CulturedCytokinesDendritic CellsHumansImmunologic FactorsMonocytesReceptor, Serotonin, 5-HT2BSignal TransductionTh17 CellsAntigens, CD1CD1a antigenCytokinesHTR2B protein, humanImmunologic FactorsReceptor, Serotonin, 5-HT2B

Identifiers

PMID29379077
PMCPMC5788853
OpenAlexW2807286371

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.